ConforMIS Inc (CFMS) Misses Q1 EPS by 4c

ConforMIS Inc (NASDAQ: CFMS) reported Q1 EPS of ($0.14), $0.04 worse than the analyst estimate of ($0.10). Revenue for the quarter came in at $16.5 million versus the consensus estimate of $18.25 million.

"The first quarter, as expected, was impacted by the coronavirus (COVID-19) pandemic, said Mark Augusti, President and Chief Executive Officer. “As previously announced, we took actions to mitigate the financial impact, as well as to ensure our employees’ safety. In addition, and as recently announced, we were able to return substantially all of our furloughed employees to work due to the financial support made available by the federal government. Though we expect the second quarter will also be impacted by the pandemic primarily due to the reduction of elective surgeries, we are pleased to see growing activity from our customers indicating the re-starting of hip and knee procedures. We look forward to getting back to business."

For earnings history and earnings-related data on ConforMIS Inc (CFMS) click here.

You May Also Be Interested In

• Gilead Sciences (GILD) Misses Q1 EPS by 288c
• Edwards Lifesciences (EW) Tops Q1 EPS by 2c; offers guidance
• SPS Commerce (SPSC) Tops Q1 EPS by 12c